Dezapelisib
Dezapelisib Uses, Dosage, Side Effects, Food Interaction and all others data.
Dezapelisib is under investigation in clinical trial NCT02456675 (INCB040093 and INCB040093 Combined With Itacitinib (INCB039110) in Relapsed/refractory Hodgkin Lymphoma).
Trade Name | Dezapelisib |
Generic | Dezapelisib |
Dezapelisib Other Names | Dezapelisib |
Type | |
Formula | C20H16FN7OS |
Weight | Average: 421.45 Monoisotopic: 421.1121075 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Dezapelisib